Biotech had a Great October Boosted by Large Cap Biopharma Leader…Update-1 AMRN, REGN
Update-1 11/5 2p EST IBB flat, NAZ up 0.185, earnings from AMRN and REGN. Amarin down 3.5% to $16.83 on earnings but bulls are waiting for label expansion. Q3 Revenues are $112.4 M up 103%, increased prescriptions for Vascepa with a 12/28/19 PADUFA date. Regeneron (REGN) up 8.25% to $336.60 on...
Small Cap Picks Update: AMRN, GNMK, TDOC…Update-2
Update-2 Genmark (GNMK) down 3.6 % to $5.61 on Q3 results. Beat on revenue to $20.9 M up 32 % over prior quarter, loss of 20 cents/share.Waiting for a buy-out in 2020? Update-1 ...Nov. 1...All of these picks are up today, IWM is up 1.6%, IJR is up 1..41% as of 3:30 p EDT. A small cap...
Biotech Momentum Picks Up: CRSP MRK XBI…Updates 10/29,31.
Update 10/30 1:45 pm EDT Markets weak on China deal, PMI data Sold CRSP at $50.with 25% gain in 2 weeks; will get back in on weakness. XBI off 0.89%, IBB down 0.85%, NAZ off 0.44%. BMY up 1.5% near 52 week highs. Teledoc (TDOC) a top 2019 small cap pick up over 12% on earnings-revenues up 24%....
Biotech Snapshot on a Lackluster Day-ALXN, BMRN…Update-10/25
Update-1 10/25 at close...A Good Day on Low Volume-NASDAQ up 0.7%, S&P is up 20.56% YTD! Large caps mixed with IBB down a tad 0.29%;leaders are BIIB,BMY,RHHBY NASDAQ-100 at record high; QQQ up 0.8% to $195.64. Gilead Sciences (GILD) a big loser on earnings miss down 4.25%. Revenue flat. XBI...
Bullish Trends in Biotech Today-Rebalance Portfolio with Healthcare…Update-1 Biogen
Update-1 10/22. Some follow through in biotech rally but sold off mirroring the NASDAQ about 2p,Maybe BREXIT related but we'll see later this week after many earnings reports. Large caps have been leading and although the IBB was up 1.66% it sold off from $107 level $106. Biogen (BIIB) helped...